EAS Newsletter October 22, 2024

Congress:

Don’t forget to submit your abstract and apply for Young Investigator Fellowships & Travel Grants!

Young Investigator Fellowships

EAS Congress programme provides younger, upcoming researchers a prestigious platform from which to launch or progress their international careers. A strong contingent of senior scientists is engaged to interact with and mentor the next generation, in the popular and well attended Science at a Glance sessions. This interaction will be a source of great inspiration and encouragement, and will ultimately strengthen research in the field.

As a measure of the Society’s commitment to encourage the leading lights of the future, EAS offers Young Investigator Fellowships to selected abstract and oral communication presenters aged 35 or under, on a competitive basis.

All applicants must fulfill the requirements and restrictions of travel. Young Investigator Fellowships for EAS Congress include:

• Complimentary Congress registration
• Complimentary 1-year EAS membership subscription
• A grant of 400 € towards travel & accommodation at the EAS Congress

Application procedures for EAS Congress:

• Application for Young Investigator Fellowship is a member benefit. To be eligible to apply for a grant, please make sure your individual membership is up to date.
• Applicants must review and understand all of the requirements and restrictions for travel (see bottom of page)
• Applicants MUST complete an application form through the congress abstract system
• Applicants MUST have submitted an abstract for presentation at EAS Congress
• Applicants MUST be 35 or under on May 31, the year of application
• The award of the Fellowships is at the discretion of the organisers
• Notifications will be sent out by February the year of the congress.

If you have reviewed and understand all of the requirements and wish to proceed with an application, please do so by completing the application when submitting your abstract.

Travel Grants to EAS Congress

These grants are awarded to selected presenters of poster or oral communications who live and work in countries where funding for international meetings is difficult to obtain.

All applicants must fulfill the requirements and restrictions of travel. The Grants are awarded at the discretion of the organisers.

The grants cover:

• Complimentary Congress registration
• Complimentary 1-year EAS membership subscription
• A grant of 400 € towards travel & accommodation at the EAS Congress

Collaborations:

Interest in Familial Hypercholesterolemia (FH)? Why not subscribe to the EAS FHSC Newsletter?

The Familial Hypercholesterolemia Studies Collaboration (FHSC) is a global initiative dedicated to improving the understanding and care of familial hypercholesterolemia (FH), a genetic condition that leads to high LDL cholesterol and increased cardiovascular risk. At present, the FHSC comprise a network of investigators from 76 countries worldwide and through its global registry, currently including more than 80,000 patients from 68 countries, the FHSC gathers real-world data on FH patients to address gaps in our knowledge of diagnosis, management and health outcomes in these patients. 
 
Recent insights from the FHSC registry in adults and children with FH have been published in The Lancet and The Lancet Diabetes & Endocrinology. Additional information on the project are also available at https://eas-fhsc.org/.  
 
By subscribing to the quarterly FHSC newsletter, you’ll receive updates on the latest news, initiatives and research from the FHSC, including the first global FHSC genetic analysis, and on opportunities for collaboration, as well as links to FH webinars for patients and clinicians. Stay informed and be part of the global effort to improve FH care!

Education:

The Atherosclerosis Journal announces new editorial leadership

Atherosclerosis is pleased to announce that Jan Borén is taking over from Arnold von Eckardstein as Editor-in-Chief of the journal, and Florian Kronenberg will assume the role of Deputy Editor-in-Chief, effective from 1st January 2025.

Jan Borén is Professor and Head of the Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, and physician at the Department of Clinical Chemistry at the Sahlgrenska University Hospital. He obtained his medical degree at the University of Gothenburg, where he also completed his PhD. His main research interest is lipid metabolism and he has focused to understand the consequences of and underlying mechanisms that lead to lipid accumulation in the liver, arterial wall and heart, with the goal of translating this knowledge into effective treatment.

His research program is translational and involves both in vitro and in vivo studies, including pathophysiological studies and mouse models, and kinetic studies in carefully phenotyped human volunteers. He is a member of the Royal Society of Arts and Sciences in Gothenburg, and has awarded numerous honours, including the Göran Gustafsson’s Prize in Medicine from the Royal Academy of Sciences, Dr. Eric K Fernström Foundation’s Research Award, and Irvine H. Page Atherosclerosis Research Award. He serves as Vice-President of the European Atherosclerosis Society (EAS), and has served several years as Co-Editor of Atherosclerosis.

Florian Kronenberg is since 2004 Professor and Director of the Institute of Genetic Epidemiology at the Medical University of Innsbruck in Austria. He received his MD from the University of Innsbruck. After his training in Medical Genetics in Innsbruck and a Postdoc at the University of Utah, USA, he headed the Research Unit “Genetic Epidemiology” at the Helmholtz-Center Munich.

His main research interests are genetic and clinical epidemiological studies on lipoprotein(a). Other topics are genetic epidemiology of lipoprotein metabolism, genetics of complex diseases such as atherosclerosis, kidney diseases, diabetes mellitus including intermediate phenotypes as well as biomarker studies. He is a Member of the Academia Europaea and served as workgroup member on several guideline and consensus initiatives (K/DOQI, KDIGO and EAS). He co-chaired the most recent EAS Consensus Statement on Lp(a). He received several rewards including the Knoll William Harvey prize and the Honorary Lifetime Membership Award of the National Lipid Association and has served several years as Co-Editor of Atherosclerosis.

In the years Professor Arnold von Eckardstein has been Editor-in-Chief of the journal, it has grown and flourished under his leadership and expertise. We would like to thank Professor von Eckardstein and Editorial Office Manager, Dr. Simona Negrini, for their contributions and hard work.

Please join us in thanking the outgoing Editor-in-Chief and Editorial Office Manager, Professor Arnold von Eckardstein and Dr. Simona Negrini, respectively, and in welcoming Professors Jan Borén and Florian Kronenberg to their new roles from January.ed Open Lecture is available to everyone until the end of the month, so make sure to catch it before it’s gone!

Education:

Explore the latest advances in FH genetic diagnosis – Prof. Mafalda Bourbon’s lecture available until the end of the month

Have you had the chance to watch Prof. Mafalda Bourbon’s talk on the latest advances in the genetic diagnosis of familial hypercholesterolemia (FH)? Just a reminder: our Featured Open Lecture is available to everyone until the end of the month, so make sure to catch it before it’s gone!

Congress:

Explore all EAS Congress 2024 sessions at EAS Academy – your learning hub!

We’re bringing back the Congress mode! As an EAS member, you have the exclusive opportunity to watch all the sessions from EAS Congress 2024. This is your chance to catch up on any missed presentations or revisit your favorite talks.

If you’re not currently an EAS member or your membership has expired, now is the perfect time to join or renew and gain access to these valuable resources.

Outreach:

Rising to the challenge: time for action on cardiovascular health

At present, more than 60 million people in the EU live with cardiovascular diseases (CVD), which remain the main cause of death and disability in Europe, accounting for over €282 billion in healthcare expenditure in the EU every year. The upcoming Council Conclusions on cardiovascular health (CVH) that the Hungarian Presidency is working on, along with the inclusion of CVD in both the European Commission President’s political guidelines and the Mission Letter to the Commissioner-Designate for Health signal a much welcome political commitment towards improving cardiovascular health (CVH) in Europe.

Building on this momentum, this event aims to provide a platform for discussion between EU and national-level stakeholders to explore ways to address CVH in Europe, reduce mortality and morbidity, and improve the quality of life of people living with or at risk of CVD.

This event will explore how to best focus EU-level action towards the unmet needs of the cardiovascular community and ensure that the new EU mandate puts forward the right tools to support the communities and the Member States in promoting CVH. The event will also see the participation of representatives of the national Health Ministries, to draw on national best practices and on the learnings of countries that have recently developed national cardiovascular health plans or other strategies to tackle CVD.

The event will be moderated by Prof. Michal Vrablik, Professor of Internal Medicine at Charles University in Prague, the Czech Republic. Speakers will include Members of the European Parliament, representatives from the European Commission, representatives of the Hungarian Presidency of the Council of the EU and patient representatives.

Society:

EAS Calendar – October-November 2024

From insightful webinars to groundbreaking announcements, this section is your gateway to staying connected and up-to-date with the latest developments within the EAS Society.

October 1 – December 3, Abstract submission for the EAS Congress 2025

October 23-25, AAS Annual Scientific Meeting

November 7-10, 40th National Congress of the Turkish Society of Cardiology